Quantcast

Latest TB Stories

2014-07-07 10:19:43

Texas A&M Health Science Center A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie. Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, in collaboration with GBDbio, a Texas A&M spinoff company,...

2014-07-03 12:54:25

European Lung Foundation The World Health Organization (WHO) today, together with the European Respiratory Society (ERS), presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33 countries and territories where there are fewer than 100 TB cases per million population. The framework outlines an initial "pre-elimination" phase, aiming to have fewer than 10 new TB cases per million people per year by 2035 in these countries....

2014-06-28 12:09:52

St. Michael's Hospital More screening may be needed Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests. Current guidelines for what constitutes a positive TB skin test among corticosteroid pill users may not be capturing all those who are infected, said Dr. Nicholas Vozoris, a respirologist in the Tuberculosis Program at St. Michael's Hospital. Previous research has shown that people who take corticosteroid pills, such as...

2014-06-10 23:02:02

Promoting the Quality of Medicines (PQM) program helps attain WHO approval for treatment of drug resistant TB. Rockville, MD (PRWEB) June 10, 2014 The US Pharmacopeial Convention (USP) is pleased to announce that with the assistance of the U.S. Agency for International Development (USAID) funded Promoting the Quality of Medicines (PQM) program, the first Active Pharmaceutical Ingredient (API) for injectables used in the treatment of multi-drug resistant tuberculosis has been assessed by...

2014-06-09 10:25:14

Queen's University TB blood test could eliminate unnecessary treatment A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives. According to research by Wendy Wobeser and medical resident Ilan Schwartz, a test for TB using interferon-gamma release assays (IGRA) will detect a pre-existing TB infection, or latent TB, that might not present itself for...

2014-05-14 08:32:24

Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates NEW YORK, May 14, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the appointment of Nader Fotouhi, Ph.D. as Chief Scientific Officer. Nader comes to the TB Alliance with nearly 25 years of experience, having served most recently as Vice President & Global Head...

2014-05-13 16:08:16

Johns Hopkins Medicine Finding supports hypothesis that the immunological functions of mucous membranes throughout the body engage in cross talk in response to infection Johns Hopkins researchers have found evidence in mice that a tuberculosis (TB) infection in the lungs triggers immune system signaling to the gut that temporarily decreases the diversity of bacteria in that part of the digestive tract. The Johns Hopkins researchers showed that this decrease in diversity of gut...

2014-04-23 16:29:42

Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that it is collaborating with, and has granted an exclusive license to, the Shanghai Fosun Pharmaceutical Development Co., Ltd., and its subsidiary Shenyang Hongqi Pharmaceutical Co., Ltd. (Fosun Pharma), to develop and...

2014-04-23 16:29:39

STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial. The announcement by Bill Gates, co-chair of the Bill...

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.